Overview

Anti-Restenosis After AMI by Erythropoietin

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The EPOC-AMI study is to assess the safety and the efficacy of systemic administration of erythropoietin for inhibition of neointimal hyperplasia after stent implantation in the patients with acute myocardial infarction

Phase:

Phase 4

Details

Lead Sponsor:

Kyoto Prefectural University of Medicine

Treatments:

Epoetin Alfa